Immune System Stimulants: Articles of Note @pharmaceuticalintelligence.com
Curators: Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
-
New Approaches to Immunotherapy
Three Methods for Design of a Novel Immune Therapy for Cancer: Conceptual Foundation for Development of a Novel Mechanism of Action for a Combination Therapy of Biologics — Password protected
Basic Research in Immune Oncology and Molecular Genomics: Methods to Stimulate Immunity by Alteration of Tumor Antigens – Reporting on R&D @MGH
New insights in cancer, cancer immunogenesis and circulating cancer cells
Perspectives on Anti-metastatic Effects in Cancer Research 2015
Issues Need to be Resolved With Immuno-Modulatory Therapies: NK cells, mAbs, and adoptive T cells
-
Current Methods of Immuno-Therapy
Checkpoint inhibitors for gastrointestinal cancers
Immunomodulatory Therapeutic Antibodies for Cancer, August 13-15, 2013 – Boston, MA – Final Agenda
Tang Prize for 2014: Immunity and Cancer
Natural Killer Cell Response: Treatment of Cancer
Viruses, Vaccines and Immunotherapy
Advances in Cancer Immunotherapy
Perspectives on Anti-metastatic Effects in Cancer Research 2015
-
Evolving Approaches including Combination Oncotherapy
LIVE – 8:00 am – 12:00 pm 4/25/2016 – First Look: The Next Wave of Cancer Breakthroughs @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston 2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Partners HealthCare, Boston, at the Westin Hotel, Boston
Brain Cancer Vaccine in Development and other considerations
Rapid regression of HER2 breast cancer
Novel biomarkers for targeting cancer immunotherapy
Humanized Mice May Revolutionize Cancer Drug Discovery
Immunomodulatory Therapeutic Antibodies for Cancer, August 13-15, 2013 – Boston, MA – Final Agenda
Melanoma: Molecule in Immune System Could Help Treat Dangerous Skin Cancer
-
Microbiological Factors in Cancer Growth
Gut microbiome and anti-tumor response
Malaria Protein Anti-cancer Activity
Oncolytic Virus Immuno-Therapy: New Approach for a New Class of Immunotherapy Drugs
-
Signaling Pathways in Oncotherapy
Protein heals wounds, boosts immunity and protects from cancer – Lactoferrin
Programmed Cell Death and Cancer Therapy
BET Proteins Connect Diabetes and Cancer
Signaling of Immune Response in Colon Cancer
Renal (Kidney) Cancer: Connections in Metabolism at Krebs cycle and Histone Modulation
Pancreatic Cancer and Crossing Roads of Metabolism
Biology, Physiology and Pathophysiology of Heat Shock Proteins
Heat Shock Proteins (HSP) and Molecular Chaperones
The Delicate Connection: IDO (Indolamine 2, 3 dehydrogenase) and Cancer Immunology
What is the key method to harness Inflammation to close the doors for many complex diseases?
IDO for Commitment of a Life Time: The Origins and Mechanisms of IDO, indolamine 2, 3-dioxygenase
Neutrophil Serine Proteases in Disease and Therapeutic Considerations
T cell-mediated immune responses & signaling pathways activated by TLRs
-
Immunogenetics in Oncotherapy
CRISPR-Cas9 and Regenerative Medicine
CRISPR/Cas9 Finds Its Way As an Important Tool For Drug Discovery & Development
GEN Tech Focus: Rethinking Gene Expression Analysis
Gene Expression and Adaptive Immune Resistance Mechanisms in Lymphoma
Serpins: A Review in Human Genomics
Upcoming Meetings on Cancer Immunogenetics
ipilimumab, a Drug that blocks CTLA-4 Freeing T cells to Attack Tumors @DM Anderson Cancer Center
NIH Considers Guidelines for CAR-T therapy: Report from Recombinant DNA Advisory Committee
Host – Tumor Interactions during Cancer Therapy – Dr. Yuval Shaked’s Lab @Technion
Demythologizing sharks, cancer, and shark fins
-
Immunotherapy Market
Monoclonal Antibody Therapy and Market
Monoclonal Antibody Therapy: What is in the name or clear description?
Tumor Associated Macrophages: The Double-Edged Sword Resolved?
Immunoreactivity of Nanoparticles
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Inflammatory Disorders: Articles published @ pharmaceuticalintelligence.com
Leave a Reply